| Literature DB >> 35426927 |
Matt Hansen1, Grace Walker-Stevenson2, Carl Eriksson3, Garth Meckler2,4, Tabria Harrod2, Nathan Bahr2, Jeanne-Marie Guise2.
Abstract
Entities:
Mesh:
Substances:
Year: 2022 PMID: 35426927 PMCID: PMC9012966 DOI: 10.1001/jamanetworkopen.2022.7645
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Epinephrine Administration by Simulation Year
| Epinephrine dose | No. of infants who received epinephrine | |
|---|---|---|
| 2016 (n = 45) | 2020 (n = 39) | |
| None | 26 | 3 |
| Any | 19 | 36 |
P < .001 by Fisher exact test for comparison of the total number of infants who received epinephrine in 2016 vs 2020.
Epinephrine Dose Category by Simulation Year
| Epinephrine dose | No. of infants who received epinephrine | |
|---|---|---|
| 2016 (n = 17) | 2020 (n = 36) | |
| Correct | 12 | 35 |
| Underdose | 2 | 0 |
| Overdose | ||
| <10× | 2 | 0 |
| 10× | 1 | 1 |
P = .01 by Fisher exact test for comparison of the total number of infants who received epinephrine in 2016 vs 2020.
Correct doses were considered to be ±20% of the recommended dose.
In 2016, we had 2 doses with unknown amounts; therefore, they were excluded from these calculations.